BIOCRYST PHARMACEUTICALS's ticker is and the CUSIP is 09058V953. A total of 3 filers reported holding BIOCRYST PHARMACEUTICALS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,171,740 | +10.2% | 165,500 | +9.5% | 0.00% | +33.3% |
| Q2 2023 | $1,063,744 | -18.1% | 151,100 | -3.0% | 0.00% | -40.0% |
| Q1 2023 | $1,298,538 | -74.4% | 155,700 | -64.8% | 0.01% | -58.3% |
| Q4 2022 | $5,075,308 | +65.5% | 442,100 | +81.6% | 0.01% | +100.0% |
| Q3 2022 | $3,067,000 | -7.6% | 243,400 | -22.4% | 0.01% | +20.0% |
| Q2 2022 | $3,320,000 | +3.0% | 313,800 | +58.3% | 0.01% | +66.7% |
| Q1 2022 | $3,223,000 | -37.2% | 198,200 | -46.5% | 0.00% | -25.0% |
| Q4 2021 | $5,129,000 | -27.1% | 370,300 | -24.4% | 0.00% | -50.0% |
| Q3 2021 | $7,036,000 | +30.7% | 489,600 | +43.8% | 0.01% | +33.3% |
| Q2 2021 | $5,382,000 | +47.0% | 340,400 | -5.5% | 0.01% | +20.0% |
| Q1 2021 | $3,662,000 | +47.8% | 360,100 | +8.3% | 0.01% | +25.0% |
| Q4 2020 | $2,477,000 | +510.1% | 332,500 | +181.5% | 0.00% | +300.0% |
| Q3 2020 | $406,000 | +123.1% | 118,100 | +210.0% | 0.00% | 0.0% |
| Q2 2020 | $182,000 | +451.5% | 38,100 | +130.9% | 0.00% | – |
| Q1 2020 | $33,000 | -13.2% | 16,500 | +51.4% | 0.00% | – |
| Q4 2019 | $38,000 | -42.4% | 10,900 | -52.8% | 0.00% | -100.0% |
| Q3 2019 | $66,000 | -91.5% | 23,100 | -88.8% | 0.00% | -85.7% |
| Q2 2019 | $778,000 | +2678.6% | 205,400 | +5768.6% | 0.01% | – |
| Q1 2019 | $28,000 | +16.7% | 3,500 | +16.7% | 0.00% | – |
| Q4 2018 | $24,000 | -36.8% | 3,000 | -40.0% | 0.00% | – |
| Q3 2018 | $38,000 | -47.2% | 5,000 | -60.0% | 0.00% | -100.0% |
| Q2 2018 | $72,000 | +166.7% | 12,500 | +119.3% | 0.00% | – |
| Q1 2018 | $27,000 | -86.0% | 5,700 | -85.5% | 0.00% | -100.0% |
| Q4 2017 | $193,000 | -81.9% | 39,300 | -80.7% | 0.00% | -90.0% |
| Q3 2017 | $1,066,000 | +199.4% | 203,500 | +217.5% | 0.01% | +150.0% |
| Q2 2017 | $356,000 | -15.0% | 64,100 | +28.5% | 0.00% | -20.0% |
| Q1 2017 | $419,000 | +28.9% | 49,900 | -2.7% | 0.01% | +66.7% |
| Q4 2016 | $325,000 | +30.5% | 51,300 | -9.2% | 0.00% | 0.0% |
| Q3 2016 | $249,000 | – | 56,500 | +56400.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 100 | -99.5% | 0.00% | -100.0% |
| Q4 2015 | $211,000 | -10.2% | 20,400 | -1.0% | 0.00% | -33.3% |
| Q3 2015 | $235,000 | -78.5% | 20,600 | -71.9% | 0.00% | -80.0% |
| Q2 2015 | $1,093,000 | +583.1% | 73,200 | +313.6% | 0.02% | +400.0% |
| Q1 2015 | $160,000 | -57.3% | 17,700 | -42.5% | 0.00% | -50.0% |
| Q4 2014 | $375,000 | +173.7% | 30,800 | +120.0% | 0.01% | +200.0% |
| Q3 2014 | $137,000 | -68.1% | 14,000 | -58.5% | 0.00% | -71.4% |
| Q2 2014 | $430,000 | +28.4% | 33,700 | +6.3% | 0.01% | +16.7% |
| Q1 2014 | $335,000 | +105.5% | 31,700 | +48.1% | 0.01% | +200.0% |
| Q4 2013 | $163,000 | -83.8% | 21,400 | -84.5% | 0.00% | -89.5% |
| Q3 2013 | $1,008,000 | +4100.0% | 138,500 | +776.6% | 0.02% | +1800.0% |
| Q2 2013 | $24,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 332,500 | $2,477,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,011 | $1,498,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |